Celadon Partners
Celadon Partners is a private equity firm established in 2018 and headquartered in Hong Kong. The firm specializes in identifying and investing in transformative innovations, concentrating on differentiated opportunities within the Greater China region. By leveraging its expertise, Celadon Partners aims to support companies that exhibit significant potential for growth and innovation, thereby contributing to the evolution of various industries in the area.
Top Stages
4 past transactions
RegCell
Seed Round in 2025
RegCell focuses on developing innovative therapies by modulating or controlling the immune system. Its primary objective is to treat patients with autoimmune diseases and cancer.
Senti Biosciences
Post in 2024
Senti Biosciences is a biotechnology company focused on synthetic biology. It develops gene circuit platforms to engineer therapeutics, with a focus on improving precision and control in cancer treatments.
NSG BioLabs
Venture Round in 2024
NSG BioLabs is a co-working laboratory designed to foster the development of innovative biotechnology ventures. Established in 2019 and headquartered in Singapore, the company offers a comprehensive global infrastructure tailored for early-stage biotech startups. Its facilities include spacious laboratory benches, multiple tissue culture suites, and access to shared core equipment, creating a collaborative environment that encourages networking and interaction among tenants and partners. By providing essential services and a supportive ecosystem, NSG BioLabs enables emerging biotechnology companies to explore and advance their business initiatives effectively.
GDMC
Series A in 2024
GDMC is a pharmaceutical company that engages in manufacturing and designing genetic medicines.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.